Summary
Microchip Technology Inc. reported strong financial results for the nine months ended December 31, 2022, with net sales increasing by 24.7% to $6.206 billion compared to the same period last year. This growth was driven by robust demand across its microcontroller and analog product lines, supported by price increases implemented throughout fiscal year 2022. The company also saw an improvement in gross margin to 67.3% from 64.9% year-over-year, attributed to higher factory utilization rates. Operationally, Microchip continues to invest in its core semiconductor products and technology licensing segments. The company generated substantial cash flow from operations, amounting to $2.91 billion for the nine months ended December 31, 2022. Despite a decrease in cash and cash equivalents by $30.5 million to $288.9 million, the company maintains a healthy liquidity position. Management expects certain supply chain constraints to persist through much of calendar 2023, though anticipates gradual improvement. Strategic initiatives include ongoing investment in R&D and manufacturing capacity expansion.
Financial Highlights
56 data points| Revenue | $2.17B |
| Cost of Revenue | $698.40M |
| Gross Profit | $1.47B |
| R&D Expenses | $282.40M |
| SG&A Expenses | $202.90M |
| Operating Expenses | $659.20M |
| Operating Income | $811.60M |
| Interest Expense | $52.80M |
| Net Income | $580.30M |
| EPS (Basic) | $1.06 |
| EPS (Diluted) | $1.04 |
| Shares Outstanding (Basic) | 549.20M |
| Shares Outstanding (Diluted) | 555.40M |
Key Highlights
- 1Net sales increased by 24.7% year-over-year to $6.206 billion for the nine months ended December 31, 2022.
- 2Gross profit margin improved to 67.3% from 64.9% year-over-year due to higher factory utilization.
- 3Microcontrollers and Analog products remain the dominant revenue drivers, representing approximately 55.9% and 28.3% of net sales respectively for the nine-month period.
- 4Net cash provided by operating activities was $2.91 billion for the nine months ended December 31, 2022, demonstrating strong operational cash generation.
- 5The company continues to invest in R&D, with R&D expenses increasing by 12.3% to $820.0 million for the nine-month period.
- 6Inventory levels increased to $1.17 billion, with days of inventory on hand at 152 days as of December 31, 2022, reflecting efforts to balance production and demand.
- 7The company repurchased $671.9 million of its common stock in the first nine months of fiscal 2023 under its $4.00 billion repurchase program.